Ensign Group insider Barry Smith sells 700 shares, a 2.9 % rule‑based move that shows confidence in the company’s solid fundamentals and growth potential.
Insightful analysis of Ensign Group’s insider sales reveals how tech adoption, policy shifts, and reimbursement trends shape its rehabilitative care future—and what it means for investors.